KALA BIO, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
KALA BIO, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2016 to Q3 2024.
  • KALA BIO, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.04M, a 15.3% decline year-over-year.
  • KALA BIO, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.67M, a 43.3% increase year-over-year.
  • KALA BIO, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.46M, a 6.49% increase from 2022.
  • KALA BIO, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.01M, a 56.4% decline from 2021.
  • KALA BIO, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.1M, a 20.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.67M $2.04M -$367K -15.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $9.04M $1.88M +$521K +38.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $8.52M $2.38M +$1.05M +79.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $7.46M $2.37M +$1.41M +147% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $6.05M $2.4M +$1.08M +81.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $4.97M $1.36M -$554K -28.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $5.53M $1.32M -$1.48M -52.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $7.01M $960K -$1.79M -65.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $8.8M $1.33M -$2.6M -66.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11.4M $1.92M -$2.79M -59.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $14.2M $2.81M -$1.9M -40.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $16.1M $2.75M -$1.31M -32.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 $17.4M $3.93M -$333K -7.82% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $17.7M $4.71M +$2.22M +88.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $15.5M $4.7M +$2.21M +88.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $13.3M $4.06M +$1.74M +74.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $11.6M $4.26M +$1.69M +65.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $9.89M $2.49M -$128K -4.88% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $10M $2.5M +$24K +0.97% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.99M $2.33M +$127K +5.78% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $9.86M $2.57M +$307K +13.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $9.56M $2.62M +$330K +14.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $9.23M $2.47M +$612K +32.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $8.62M $2.2M +$697K +46.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-12
Q3 2018 $7.92M $2.27M +$1.28M +131% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $6.63M $2.29M +$1.72M +304% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $4.91M $1.86M +$1.34M +257% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $3.57M $1.5M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $981K +$427K +77.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $567K -$301K -34.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $522K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q3 2016 $554K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $868K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.